NVNO Latest Press Releases

-- November 2, 2026 --

enVVeno Medical to Showcase the enVVe System at 38th Annual Transcatheter Cardiovascular Therapeutics (TCT) Scientific Symposium ACCESS Newswire 8:43 AM

-- October 30, 2026 --

enVVeno Medical Reports Third Quarter 2026 Financial Results and Prepares to Treat First Patients in FDA-Approved TAVVE Pivotal Study ACCESS Newswire 8:30 AM

-- October 21, 2026 --

enVVeno Medical Releases New Episode of "WTF" Video Series Featuring CEO Rob Berman ACCESS Newswire 8:44 AM

-- October 2, 2026 --

enVVeno Medical's First-in-Class enVVe System to Be Featured at The VEINS 2026 Innovation Summit as Company Advances Toward U.S. Pivotal Trial ACCESS Newswire 8:44 AM

-- September 16, 2026 --

enVVeno Medical CEO Rob Berman Goes Direct to Investors with New "WTF" Video Series ACCESS Newswire 8:50 AM

-- September 11, 2026 --

enVVeno Medical Presentation from H.C. Wainwright Conference Now Available On-Demand ACCESS Newswire 7:00 AM

-- August 27, 2026 --

enVVeno Medical Participates in the Virtual Investor 'Why Now' On-Demand Conference ACCESS Newswire 9:01 AM

JTC Team Releases Virtual Investor "Why Now" On-Demand Conference Featuring Nine Public Company CEOs ACCESS Newswire 9:01 AM

-- August 4, 2026 --

Independent Health Economic Study Recently Published in Journal of Vascular Surgery Reports Economic Dominance of enVVeno Medical's Replacement Venous Valve Therapy Compared to Standard of Care Treatments ACCESS Newswire 8:46 AM

-- July 31, 2026 --

enVVeno Medical Reports Second Quarter 2026 Financial Results and Advances Towards FDA Pivotal Trial for First-in-Class Non-Surgical Replacement Venous Valve ACCESS Newswire 8:30 AM

-- July 15, 2026 --

enVVeno Medical Highlights Newly Issued U.S. Patent Strengthening Competitive Position Ahead of Historic Pivotal Trial in Virtual Investor "What This Means" Segment ACCESS Newswire 8:30 AM

-- July 7, 2026 --

enVVeno Medical Secures Transformational U.S. Patent for enVVe System, Strengthening Competitive Moat Ahead of Launch of Historic FDA Pivotal Trial ACCESS Newswire 8:29 AM

-- June 22, 2026 --

enVVeno Medical to Present in the Webull Corporate Connect Webinar Series ACCESS Newswire 9:00 AM

Market Data Delayed 15 Minutes